KR100616067B1 - Anticancer composition containing rubus coreanus extract - Google Patents

Abstract

 The present invention relates to an anticancer composition comprising bokbunja extract. In particular, the present invention provides an anticancer composition comprising a bokbunja extract capable of exhibiting a specific proliferation inhibitory effect on cancer cells, inhibiting DNA synthesis of cancer cells, and inducing cancer cell death (apoptosis).

Bokbunja, anticancer

Description

Anticancer composition containing Bokbunja extract {ANTICANCER COMPOSITION CONTAINING RUBUS COREANUS EXTRACT}

1A to 1D are graphs showing the cancer cell proliferation inhibitory effect of bokbunja water extract (mean ± SEM, n = 6), a is HT-29 cells, colorectal cancer cells, b is DU145 cells, prostate cancer cells, c Is MCF-7 cells which are breast cancer cells and d is IEC-6 cells which are normal cells derived from the small intestine epithelium of white rats.

Figure 2 is a graph (mean ± SEM, n = 6) showing the proliferation inhibitory effect on HT-29 cells, colon cancer cells of bokbunja ethanol extract.

3 is a graph (mean ± SEM, n = 6) showing the proliferation inhibitory effect on HT-29 cells, colon cancer cells of the bokbunja water extract fraction (40 ㎍ / ml).

Figure 4 is a graph showing the DNA synthesis inhibitory effect in colon cancer cells by bokbunja water extract.

Figure 5 shows fragmentation of DNA in colon cancer cells by bokbunja water extract.

Figure 6 shows the induction of apoptosis of colorectal cancer cells HT-29 by bokbunja water extract.

[TECHNICAL FIELD OF THE INVENTION]

The present invention relates to an anticancer composition comprising a bokbunja extract, and more particularly to a bokbunja extract that includes a proliferation inhibitory effect specific to a cancer cell line, inhibits cancer cell DNA synthesis, and induces apoptosis of cancer cells. It is about.

[Private Technology]

With the development of the economy and the westernization of diet, changes in the forms of diseases that occur are leading to a dramatic increase in cancer incidence and mortality from cancer. According to the 2002 Report of the Korea Central Cancer Registration Project, there were 99,025 cancer patients registered in 2002, an increase of 7.7% compared to 2001 (Korea Central Cancer Registration Project 2002 Report, 2004). In addition, 25.4% of males and 14.0% of females were more likely to die of various cancers, and cancer was the leading cause of death along with circulatory diseases (2001 Lifeline Results, 2004). Changes in the environment also lead to changes in the parts of the body where cancer occurs, and the incidence of colorectal cancer, prostate cancer, and breast cancer, which have been relatively infrequent, is increasing rapidly (Korea Central Cancer Registration Report 2002, 2004).

Cancer treatment is conventionally limited to the site where the cancer first occurred and if it has not spread to other sites, surgery and radiation therapy are performed. Patients whose cancer has spread or spread metastasized or relapsed are treated with anticancer drugs. Chemotherapy was performed. Recently, however, prophylactic chemotherapy is often performed to prevent recurrence or complete healing after radical surgery or radiation therapy. However, the chemotherapy administered to patients in chemotherapy does not pick and kill only cancer cells, and thus damages normal cells. This causes various side effects, resulting in cancer prevention and anticancer drugs having excellent side effects of cancer prevention and treatment. Development is urgently required.

As part of the development of cancer prevention agents and anticancer drugs that do not have side effects, researches to find substances with anticancer efficacy from natural products are actively conducted in various countries around the world, and anticancer researches such as native vegetables and medicinal plants are being conducted in Korea. (Hwang YK et al., 1998; Kim JB et al., 2001; Bae JH & Kim JE, 2004; Yim HB et al., 2004).

On the other hand, Bokbunja refers to the less ripe fruit, immature fruit of Rubus coreanus , a deciduous shrub of the Rosaceae family. Bokbunja has been used for edible food since ancient times, and is used as a medicinal herb for the purpose of treatment in Chinese medicine or in the private sector. Bokbunja are known to have interpolation, nominal and diuretic effects (Bae GH. The medicinal plants of korea. P.231 Kyohak Publishing Co. Ltd, 2000).

It was found that the stem of Rubus Koreanum contained tannin component (-)-epicatechin, (+)-catechin and proanthocyanidins (Lee YA & Lee MW, Korean J Pharmacogn 26: 27-30, 1995 ), Various flavonoid compounds were identified in the leaves (Lee MW. Yakhak Hoeji 39: 200-204, 1995; Kim MS, Pang GC, Lee MW. Yakhak Hoeji 41: 1-6, 1997). In addition, the physiological activity of the extracts was determined according to the extraction method of immature fruit, ripe fruit and leaf of Rubus Koreanum. The results of the experiment showed no difference according to the extraction solvent. It was confirmed that the nitrite scavenging rate was excellent and the SOD (superoxide dismutase) -like activity was lower than that of mature fruit (Cha HS, Park MS, Park KM. Korean J Food Sci Technol 33 (4): 409-415, 2001) . Also, Yoon et al. (Yoon I, Cho JY, Kuk JH, Wee JH, Jang MY, Ahn TH, Park KH.Korean J Food Sci Technol 34 (5): 898-904, 2002) 4-hydroxybenzoic acid, 4-hydroxy-3-methoxybenzoic acid, 3,4-dihydroxybenzoic acid, 3,4,5-trihydroxybenzoic acid, having antioxidant activity in soluble acid fractions, 3 , 4-dihydroxycinnamic acid and the like have been identified and reported.

However, only studies on the antioxidant activity of the Rubus Koreanum extract is in progress, and there is no direct study on the effect of preventing or treating certain diseases, especially cancer.

In order to solve the problems of the prior art, an object of the present invention is to provide an anticancer composition comprising a bokbunja extract.

In addition, an object of the present invention is to provide an anticancer composition comprising a bokbunja extract having excellent anticancer effect and no side effects.

In order to achieve the above object, the present invention provides an anticancer composition comprising bokbunja extract as an active ingredient.

Hereinafter, the present invention will be described in detail.

The inventors of the present invention, while studying an anticancer agent in a plant to ensure human safety, confirmed that the bokbunja extract can specifically inhibit cancer cell proliferation and induce cancer cell apoptosis, to complete the present invention based on this.

The present invention relates to an anticancer composition comprising bokbunja extract as an active ingredient. Bokbunja can be purchased and used in the market, or may use immature or mature fruit of the bokbunja tree.

Bokbunja extract can be prepared by extracting and / or fractionating with water or an organic solvent. The organic solvent may be a low-cost alcohol having 1 to 5 carbon atoms or alcohol dilution water, hexane, chloroform, ethyl acetate and acetone, the low alcohol may be ethanol, methanol, butanol, propanol and isopropanol, but is not limited thereto. . Preferably, bokbunja water extract extracted with hot water with water, ethanol extract extracted with distilled ethanol water, bokbunja ethyl acetate extract obtained by layering the bokbunja water extract with ethyl acetate, or the bokbunja water acetate layered with ethyl acetate to extract bokbunja ethyl acetate extract The residue left after removal may be a fraction eluted on a column filled with polystyrene / divinylbenzene resin. The fractions can be obtained respectively depending on the eluting solvent, such as distilled water, alcohol or alcohol dilution water, preferably by eluting with 50% ethanol.

For example, bokbunja extract is performed by adding 0.2 to 2 L of water or an organic solvent per 100 g of bokbunja and then separating the extract or the separated separation. Extraction and separation temperature may be 4 to 120 ℃, but is not limited thereto. Bokbunja water extract is good to extract hot water at 50 to 120 ℃. Extraction time is not limited but may be 2 to 24 hours. The extract and aliquot are then filtered under reduced pressure and lyophilized to remove the solvent.

The bokbunja extract according to the present invention inhibits the proliferation of cancer cell lines, in particular, the bokbunja water extract shows a significant cancer cell proliferation inhibitory activity against prostate cancer, breast cancer and colorectal cancer cells (Fig. 1a-1c). On the other hand, it shows very low levels of cell proliferation inhibitory activity against normal cells (FIG. 1D). As well as bokbunja ethanol extract (Fig. 2), bokbunja ethyl acetate extract (Fig. 3) and bokbunja fraction (Fig. 3) also has a significant anti-cancer activity. The anticancer activity is presumed to be related to the effect of inhibiting cancer cell DNA synthesis (FIG. 4) and cancer cell death induction (FIG. 5 and 6) of the bokbunja extract.

 Thus, the present invention provides an anticancer composition comprising the bokbunja extract as an active ingredient. The bokbunja extract is preferably bokbunja water extract, bokbunja ethanol extract, bokbunja ethyl acetate extract or bokbunja fraction.

The anticancer composition of the present invention may include each of the above active ingredients alone, and may further include a pharmacologically acceptable carrier or excipient according to the formulation, method of use, and purpose of use. When provided in a mixture, the active ingredient may be included in the antioxidant composition in an amount of 0.1 to 99.9% by weight, but is preferably included in an amount of 0.001 to 50% by weight. The anticancer composition can be used for the purpose of preventing and treating various cancers such as gastric cancer, breast cancer, colon cancer, prostate cancer or liver cancer.

The carrier or excipient includes water, dextrin, calcium carbonate, lactose, propylene glycol, liquid paraffin, physiological saline, dextrose, sucrose, sorbitol, mannitol, ziitol, erythritol, maltitol, starch, gelatin, calcium phosphate, calcium silicate , Cellulose, methyl cellulose, polyvinylpyrrolidone, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, which may be used one or more, but are not limited to these, and are common carriers And excipients are both available. In addition, when the anticancer composition is formulated, conventional fillers, extenders, binders, disintegrating agents, surfactants, anticoagulants, lubricants, wetting agents, flavoring agents, emulsifiers, or preservatives may be further included.

The anticancer composition of the present invention can be used as a medicament, food, food additive, beverage or beverage additive. The anticancer composition may be used orally or parenterally, but is preferably oral administration. The anticancer composition may be an anticancer agent when used as a medicine, and when used as a food, a food additive, a beverage or a beverage additive, various foods, meats, beverages, chocolate, snacks, confectionary, pizza, ramen, other noodles, gums, ice cream Alcohols, alcoholic beverages, vitamin complexes, alcoholic beverages, and other health supplements, but are not limited thereto. At this time, the anticancer composition may be included in 0.001 to 50% by weight in the final drug, food or beverage, but is not limited thereto.

The dosage form of the anticancer composition may be in a preferred form depending on the method of use, and is preferably formulated by employing methods known in the art to provide rapid, sustained or delayed release of the active ingredient after administration to a mammal. . Examples of specific formulations include warnings, granules, lotions, linings, limonades, powders, syrups, ointments, liquids, aerosols, EXTRACTS, elixirs, ointments, liquid extracts, emulsions, Suspensions, premises, acupuncture, eye drops, tablets, suppositories, injections, spirits, capsules, creams, pills, soft or hard gelatin capsules.

The dosage of the anticancer composition according to the present invention may be determined in consideration of the method of administration, the age, sex and weight of the recipient, and the severity of the disease. For example, the anticancer composition of the present invention may be administered at least once at 0.1 to 100 mg / kg (body weight) per day based on the active ingredient. However, the above dosage is only one example to illustrate and is not limited to the above range.

Hereinafter, examples of the present invention will be described. The following examples are only for illustrating the present invention and the present invention is not limited to the following examples.

Example 1: Preparation of Bokbunja Water Extract

Bokbunja purchased immature fruits of bokbunja berries as dried. 100 g of bokbunja was added to 1 L of distilled water, and heated to 100 ° C. for 12 hours to extract. The extract was filtered by Whatman filter and then frozen at -70 ° C and dried to a powdery state with a freeze dryer.

Example 2: Preparation of Bokbunja Ethanol Extract

100 g of bokbunja was added to 1 L of 95% ethanol, heated to 70 ° C., extracted for 12 hours, and filtered using Whatman filter paper. The filtrate was prepared by removing and concentrating ethanol with a vacuum rotary evaporator and then drying it to a powder state with a lyophilizer.

Example 3: Preparation of Bokbunja Fraction

18 g of the dried Bokbunja water extract prepared by the method of Example 1 was dissolved in 200 ml of distilled water, and ethanol (alcohol) was added thereto to make the ethanol concentration 70%, and left at 4 ° C. for 24 hours to obtain an insoluble polymer material (fraction). 1) and 70% ethanol soluble aqueous solution (fraction 2). Fraction 2 was concentrated to remove ethanol, ethyl acetate was added thereto, and fractionation was carried out to separate low molecular weight nonpolar substances (fraction 3) and residues (fraction 4), respectively. Fraction 4 was concentrated to remove the solvent, dissolved in distilled water, and injected into a column (40 mm × 500 mm) filled with ion exchange resin (Diaion HP-20). 100% of distilled water was used as the eluting solvent to obtain an eluted fraction as fraction 5, and distilled water and an ethanol mixture (1: 1 volume) were secondly flowed as an eluting solvent to obtain an eluted fraction 6, which was then diluted to 100% of ethanol. Spilled to give fraction 7 eluted.

Fractions 1 to 7 obtained above were powdered by concentration under reduced pressure and lyophilization, respectively.

Experimental Example

end. Cancer Cell Lines and Reagents

Human colon cancer cells HT-29 cells, human prostate cancer cells DU145 cells, human breast cancer cells MCF-7 cells and small rat small intestinal epithelial cells IEC-6 cells are ATCC (American Type Culture Collection, Rockville) , MD, USA). DMEM / F12 (Dulbecco's Modified Eagle's Medium: Nutrient Mixture Ham's F12) was used as the cell medium. , MD, USA). Reagents such as BSA (Bovine serum albumin, DMSO (dimethysulpoxide), 7-amino-actinomycin D, and MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide) are Sigma Chemical Co. Annexin V Phycoerythrin (PE) was also used in BD Biosciences Phamingen (Franklin Lakes, NJ, USA) for cell proliferation ELISA and BrdU (colorimetric) assay kits. Was purchased from Roche Molecular Biochemicals (Mannheim, Germany) and a disposable sterile container used for cell culture was purchased from Corning (Corning, NY, USA).

I. Cell culture

HT-29 cells, DU145 cells, MCF-7 cells and IEC-6 cells were cultured in a 37 ° C wet CO ₂ incubator (5% CO ₂ /95% air).

HT-29 cells, DU145 cells, and MCF-7 cells were cultured in a culture medium containing 10% FBS, 100 units / ml penicillin and 100 μg / ml streptomycin in DMEM / F12 medium, and IEC-6 cells were added to Cultivation was carried out in medium to which μg / ml insulin was further added. When the cells were incubated with 80% confluent, the monolayers of cells were washed with PHS (phosphate-buffered saline, pH 7.4), followed by subculture with 0.25% trypsin-2.65 mM EDTA, and the medium was replaced every two days.

All. Validation of Cancer Cell Proliferation Inhibitory Effect of Bokbunja Extract

Each cancer cell was diluted with medium containing FBS and aliquoted into 24 well plates at a density of 50,000 cells / well. After 24 hours, the cells were replaced with FBS-free serum deficient medium (DMEM / F12, transferrin 5 μg / ml, selenium 5 ng / ml, BSA 0.1 mg / ml) and then incubated for 24 hours. Thereafter, the bokbunja extracts of Examples 1 to 3 were prepared by replacing the serum deficient medium each containing a concentration. The bokbunja water extract of Example 1 was used by dissolving in serum deficient medium, and the bokbunja ethanol extract of Example 2 was used by dissolving in DMSO, and the fraction of each bokbunja water extract of Example 3 was dissolved in serum deficient medium. Used at a concentration of μg / ml. In the experiment of Bokbunja extract II, the same amount (0.4%) of DMSO was added to all groups to exclude the effect of DMSO.

24 hours or 48 hours of incubation after the addition of Bokbunja extract was performed, and the number of living cells was measured by MTT analysis (Denizot F, Lang R. J Immunological Methods 1986; 89: 271-277.). The impact was investigated. The MTT assay is based on the principle that succinate-dehydrogenase present in the mitochondria reduces MTT to form a blue formazan. The experiment was performed as follows. After removal of the cell culture, 1 ml of DMEM / F12 containing MTT at a concentration of 1 mg / ml was added to the 24-well plate at 1 ml per well, followed by 3 in a 37 ° C. wet CO ₂ incubator (5% CO ₂ /95% air). Time incubation. After removing the medium, formazan was dissolved by adding 0.5 ml isopropanol, and the absorbance was measured at a wavelength of 570 nm.

1A to 1D are graphs showing the cancer cell proliferation inhibitory effect of bokbunja water extract (mean ± SEM, n = 6), a is HT-29 cells, colorectal cancer cells, b is DU145 cells, prostate cancer cells, c Is MCF-7 cells which are breast cancer cells and d is IEC-6 cells which are normal cells derived from the small intestine epithelium of white rats.

1a to 1d, colon cancer cell proliferation inhibitory effect by the bokbunja water extract appeared from 24 hours after the addition of bokbunja water extract and the cell proliferation inhibitory effect appeared remarkably with time, depending on the treatment concentration of bokbunja water extract Cell proliferation was inhibited (FIG. 1A). In addition, bokbunja water extract significantly inhibited cell proliferation of DU145 cells, prostate cancer cells, and inhibited cell proliferation of about 71.5% after 48 hours when bokbunja water extract was added at a concentration of 400 μg / ml (FIG. 1B). In breast cancer cells, the inhibitory effect on cell proliferation by bokbunja water extract was observed, but was lower than that in colon cancer cells and prostate cancer cells (FIG. 1C). In addition, the effect of bokbunja water extract on the proliferation of normal cells showed no significant inhibitory effect on the proliferation of IEC-6 cells 24 hours after bokbunja water extract treatment, 200 ㎍ / ㎖ or 400 ㎍ at 48 elapsed Cell growth inhibition of 14.5% and 16.8% was observed in the group treated with / ml, respectively (Fig. 1d), which is significantly lower than the cancer cell growth inhibition effect.

Figure 2 is a graph (mean ± SEM, n = 6) showing the proliferation inhibitory effect on HT-29 cells, colon cancer cells of bokbunja ethanol extract. Cell proliferation was inhibited in proportion to the treatment concentration of bokbunja ethanol extract, and after 48 hours, cell proliferation inhibitory effects were observed at concentrations of 200 μg / ml and 400 μg / ml, respectively. However, when the bokbunja water extract in the HT-29 cells treated with 400 ㎍ / ㎖ concentration in Figure 1a, the cell proliferation is suppressed as compared to about 51.5% suppressed, which is compared to the bokbunja ethanol extract It has a strong cancer cell proliferation inhibitory effect.

3 is a graph (mean ± SEM, n = 6) showing the proliferation inhibitory effect on HT-29 cells, colon cancer cells of the bokbunja water extract fraction (40 ㎍ / ㎖). Bokbunja water extract fractions 1-7 showed various effects on colorectal cancer cell proliferation, especially fractions 3-7 showed cell proliferation inhibitory effect, of which fraction 6 was very remarkable.

la. Validation of DNA Synthesis Inhibitory Effect of Bokbunja Extract

In order to investigate the effect of bokbunja extract on the DNA synthesis of cells, the degree of BrdU (5-bromo-2'-deoxyuridine) was inserted into the DNA of the cells was measured.

Colon cancer cells, HT-29, were diluted in a medium containing FBS and dispensed into a 96 well plate at a density of 6,000 cells / well, cultured in serum deficient medium for 24 hours, and then bokbunja water extract was 100 to 200. It was added at ㎍ / ㎖ and further incubated for 48 hours. After incubating for 5 hours by adding 10 μM BrdU to the cells, the cells were fixed and incubated for 90 minutes with the addition of anti-BrdU-POD. After tetramethyl-benzidine was reacted with the substrate for 15 minutes, 1M H ₂ SO ₄ was added to stop the reaction, and the absorbance was measured at 450 nm. The experiment was carried out using a cell proliferation ELISA, BrdU (colorimetric) assay kit.

Figure 4 is a graph showing the inhibitory effect of DNA synthesis in colon cancer cells by bokbunja water extract, it can be seen that the bokbunja water extract significantly inhibits the DNA synthesis of colon cancer cells.

hemp. Verification of Induction Effect of Cancer Cell Apoptosis by Bokbunja Extract

i) DNA fragmentation measurement

Colon cancer cell HT-29 was dispensed into a 100 mm culture plate at a density of 2 × 10 ⁶ cells / culture plate and treated with bokbunja water extract in the same manner as the above experiment. After culturing for 48 hours with the addition of Bokbunja extract, cells were collected by scraping the cells into cold PBS and centrifuging at 2000 rpm for 5 minutes. Extracted buffer (50 mM Tris, 20 mM EDTA, 1% Nonidet P-40, pH 7.5) was added to the collected cells and stirred at 4 ° C for 2 hours. Then add SDS to 1% and stir at 4 ° C. for 2 hours, add RNase A (0.5 mg / mL) for 2 hours at 37 ° C., and add proteinase K (0.5 mg / mL) at 42 ° C. Stir for 2 hours. A mixture of phenol-chloroform-isoamyl alcohol (25: 24: 1) in the same amount as the total volume was added and mixed well, followed by centrifugation to obtain a supernatant. 0.3 M sodium acetate and 2.5% volume of 100% ethanol were added to the supernatant to precipitate DNA, and the DNA was washed with 70% ethanol and dried. The dried DNA was dissolved in TE buffer (20 mM Tris, 1 mM EDTA), quantified by measurement of absorbance at 260 nm and 280 nm, and electrophoresed with 20 μg of DNA on 1.5% agarose gel, followed by EtBr (ethidium). Bromide) was used to observe the pattern of the developed DNA band.

Figure 5 shows the fragmentation of colorectal cancer cell DNA by the bokbunja water extract, the oligonucleotide fragmentation characteristic that appears early in the cell apoptosis was remarkably observed.

ii) Fluorescence-activated cell sorting (FACS) analysis

50,000 colon cancer cells HT-29 The cells were dispensed in a 24-well plate at the density of cells / culture plate, and the bokbunja water extract was treated in the same manner as the above experiment. After 48 hours, cells were collected by treatment with trypsin-EDTA, and stained for 20 minutes in the dark by adding 7-amino-actinomycin D (7-AAD) and Annexin V. The number of cells stained with Annexin V or 7-amino-actinomycin D was then measured in flow cytometry.

Figure 6 shows the induction of apoptosis of colorectal cancer cells HT-29 by bokbunja water extract, the number of viable cells decreased depending on the concentration of bokbunja water extract treatment, the initial cell apoptosis was dependent on the treatment concentration Significantly increased. These results suggest that one of the mechanisms that act on the inhibition and killing of cancer cell proliferation of bokbunja water extract is induction of apoptosis.

As described above, the bokbunja extract of the present invention shows a specific proliferation inhibitory effect on cancer cell lines, including cancer cell DNA synthesis inhibition and cancer cell death inducing activity, can be easily used for the prevention and treatment of various cancers Do.

Claims (8)

Anticancer composition comprising bokbunja extract as an active ingredient. The composition of claim 1, wherein the composition comprises 0.001 to 50% by weight of bokbunja extract. The composition of claim 1, wherein the bokbunja extract is extracted from bokbunja with a solvent selected from the group consisting of water, alcohol, alcohol dilution water, ethyl acetate and mixtures thereof. The method of claim 1, wherein the bokbunja extract (a) bokbunja hot water extract manufacturing step; (b) adding 70% ethanol to the dried bokbunja hot water extract to separate an ethanol-soluble aqueous solution; (c) separating the ethanol soluble aqueous solution by adding ethyl acetate after removing ethanol; (d) removing the nonpolar material and separating the residue in the ethyl acetate layer separation; And (e) The residue is concentrated to remove the solvent, dissolved in distilled water and poured into a column filled with polystyrene / divinylbenzene resin, followed by chromatography using a mixture of distilled water and ethanol in a 1: 1 volume ratio as the elution solvent. Carrying out photography; Composition prepared by the method comprising a. The anticancer composition of claim 1, wherein the composition is a medicament. The anticancer composition according to claim 1, wherein the anticancer composition is applied to breast cancer, colon cancer or prostate cancer. The anticancer composition according to claim 1, wherein the composition is a food or food additive. The anticancer composition of claim 1 wherein the composition is a beverage or beverage additive.

Images